Discovery of novel biphenyl-substituted pyridone derivatives as potent non-nucleoside reverse transcriptase inhibitors with promising oral bioavailability.

MLA

Zhao, Li-Min, et al. “Discovery of Novel Biphenyl-Substituted Pyridone Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Oral Bioavailability.” European Journal of Medicinal Chemistry, vol. 240, Oct. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2022.114581.

APA

Zhao, L.-M., Wang, S., Pannecouque, C., De Clercq, E., Piao, H.-R., & Chen, F.-E. (2022). Discovery of novel biphenyl-substituted pyridone derivatives as potent non-nucleoside reverse transcriptase inhibitors with promising oral bioavailability. European Journal of Medicinal Chemistry, 240, N.PAG. https://doi.org/10.1016/j.ejmech.2022.114581

Chicago

Zhao, Li-Min, Shuai Wang, Christophe Pannecouque, Erik De Clercq, Hu-Ri Piao, and Fen-Er Chen. 2022. “Discovery of Novel Biphenyl-Substituted Pyridone Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Oral Bioavailability.” European Journal of Medicinal Chemistry 240 (October): N.PAG. doi:10.1016/j.ejmech.2022.114581.